Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-18T22:05:46.254Z Has data issue: false hasContentIssue false

Microstructural Characterization of Polyanhydride Blends for Controlled Drug Delivery

Published online by Cambridge University Press:  15 March 2011

Elizabeth E. Shen
Affiliation:
Department of Chemical & Biochemical EngineeringRutgers University98 Brett Road Piscataway, NJ 08854, U.S.A
Hsin-Lung Chen
Affiliation:
Department of Chemical EngineeringNational Tsing-Hua University Hsinchu, Taiwan
Balaji Narasimhan
Affiliation:
Department of Chemical & Biochemical EngineeringRutgers University98 Brett Road Piscataway, NJ 08854, U.S.A
Get access

Abstract

This research examines the microstructure of polyanhydride blends for use in drug delivery devices. Atomic force microscopy (AFM) and small-angle X-ray scattering (SAXS) studies were performed on the homopolymers and blends of the polyanhydrides poly(1,6-carboxyphenoxy hexane) (CPH) and poly(sebacic anhydride) (SA). AFM of the CPH/SA blends 20:80, 50:50, and 80:20 showed distinct patterns indicating spinodal decomposition and phase separation on the micron-scale. Because it has been shown that incorporated drugs will thermodynamically partition into phase-separated domains depending on their hydrophobicity, polyanhydride blends will be able to encapsulate larger bioactive compounds including nucleotides, proteins, and vaccines. Preliminary SAXS studies of the CPH/SA blend systems provide information on the crystalline morphology of the polymer. A peak shift to a lower q from poly(SA) to the blends indicates that the poly(CPH) is incorporated into and causes swelling of the interlamellar amorphous regions of poly(SA).

Type
Research Article
Copyright
Copyright © Materials Research Society 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Leong, K.W., Brott, B.C., and Langer, R., Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J. Biomed. Mat. Research, 1985. 19: p. 941955.Google Scholar
2. Leong, K. et al. , Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. J. Biomed. Mat. Res., 1986. 20: p. 5164.Google Scholar
3. Goepferich, A., Polymer degradation and erosion: Mechanisms and applications. Eur. J. Pharm. Biopharm., 1996. 42(1): p. 111.Google Scholar
4. Goepferich, A., Mechanisms of polymer degradation. Biomaterials, 1996. 17(2): p. 103114.Google Scholar
5. Tamada, J. and Langer, R., Review: The development of polyanhydrides for drug delivery applications. J. Biomater. Sci. Polymer Edn, 1992. 3(4): p. 315353.Google Scholar
6. Chasin, M., Lewis, D., and Langer, R., Polyanhydrides for controlled drug delivery. Biopharm. Mfg., 1988. February: p. 3339.Google Scholar
7. Tamada, J.A. and Langer, R.S., Mechanism of the erosion of polyanhydride drug delivery systems. Proced. Intern. Symp. Control. Rel. Bioact. Mater., 1990. 17: p. 156157.Google Scholar
8. Shen, E. et al. , Microphase separation in bioerodible copolymers for drug delivery. Biomaterials, 2000. 22(3): p. 201210.Google Scholar
9. Domb, A.J. and Langer, R., Polyanhydrides I. Preparation of high molecular weight polyanhydrides. J. Polym. Sci: Part A: Polym. Chem., 1987. 25: p. 33733386.Google Scholar
10. Mathiowitz, E. et al. , Morphological characterization of bioerodible polymers. 1. Crystallinity of polyanhydride copolymers. Macromolecules, 1990. 23: p. 32123218.Google Scholar